Literature DB >> 18608468

Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition.

Dave A Miller1, James C DiNunzio, Wei Yang, James W McGinity, Robert O Williams.   

Abstract

Previous attempts to improve the dissolution and absorption properties of itraconazole (ITZ) through advanced formulation design have focused only on release in acidic media; however, recent reports indicate that absorption occurs primarily in the proximal small intestine. This suggests that enhancing supersaturation of ITZ in neutral aqueous environments is essential for improving absorption. The aim of this study was to evaluate different polymeric stabilizers with either immediate release (IR) (Methocel E5, Methocel E50, Kollidon 12, and Kollidon 90) or enteric release (EUDRAGIT L 100-55, HP-55, and HP-55S) properties to determine the chemical and physical attributes of the polymeric stabilizers that promote supersaturation of ITZ in neutral media. Each amorphous composition was produced by hot-melt extrusion and characterized by differential scanning calorimetry. Dissolution testing by a supersaturated acidic-to-neutral pH change method was conducted on each composition. Testing of IR compositions revealed that Methocel was a superior stabilizer compared with Kollidon owing to stronger intermolecular interaction with ITZ molecules in solution. Increasing the molecular weight of polymers was found to promote ITZ supersaturation and was most likely attributable to increased solution viscosity resulting in retention of ITZ molecules in an enthalpically favored association with the polymer for extended durations. Of the enteric polymeric stabilizers, EUDRAGIT L 100-55 was found to be superior to both HP-55 grades because of its greater permeability to acid that allowed for improved hydration of ITZ in the acid phase as well as a greater number of free hydroxyl groups on the polymer backbone that presumably helped to stabilize ITZ in solution. The Methoceltrade mark E50 and EUDRAGIT L 100-55 formulations were evaluated for in vivo drug absorption in male Sprague-Dawley rats and were found to produce a threefold greater ITZ absorption over our previously reported IR formulations. The results of this study confirmed the hypothesis that supersaturation of ITZ following an acidic-to-neutral pH transition in vitro correlates directly to in vivo absorption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608468     DOI: 10.1080/03639040801929273

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  25 in total

1.  Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).

Authors:  Chris Brough; Dave A Miller; Daniel Ellenberger; Dieter Lubda; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2016-02-10       Impact factor: 3.246

2.  pH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties.

Authors:  Yi-Ling Hsieh; Grace A Ilevbare; Bernard Van Eerdenbrugh; Karl J Box; Manuel Vincente Sanchez-Felix; Lynne S Taylor
Journal:  Pharm Res       Date:  2012-05-12       Impact factor: 4.200

3.  Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.

Authors:  Harsh Chauhan; Anuj Kuldipkumar; Timothy Barder; Ales Medek; Chong-Hui Gu; Eman Atef
Journal:  Pharm Res       Date:  2014-02       Impact factor: 4.200

4.  Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.

Authors:  Justin R Hughey; James C DiNunzio; Ryan C Bennett; Chris Brough; Dave A Miller; Hua Ma; Robert O Williams; James W McGinity
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

5.  Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.

Authors:  Justin S LaFountaine; Leena Kumari Prasad; Chris Brough; Dave A Miller; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-10-13       Impact factor: 3.246

6.  Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.

Authors:  Julien P Maincent; Laura K Najvar; William R Kirkpatrick; Siyuan Huang; Thomas F Patterson; Nathan P Wiederhold; Jay I Peters; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2016-10-05       Impact factor: 3.225

7.  In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersions.

Authors:  Zahra N Mahmoudi; Sampada B Upadhye; David Ferrizzi; Ali R Rajabi-Siahboomi
Journal:  AAPS J       Date:  2014-05-02       Impact factor: 4.009

8.  Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.

Authors:  Tapan Parikh; Harpreet K Sandhu; Tanaji T Talele; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2016-03-07       Impact factor: 4.200

9.  Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption.

Authors:  Dave A Miller; James C DiNunzio; Wei Yang; James W McGinity; Robert O Williams
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

10.  Soluble itraconazole in tablet form using disordered drug delivery approach: critical scale-up considerations and bio-equivalence studies.

Authors:  Shankar Swaminathan; Mayur Sangwai; Sharad Wawdhane; Pradeep Vavia
Journal:  AAPS PharmSciTech       Date:  2013-01-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.